GREAT NEWS: HEALTH CANADA APPROVES FIRST ADJUVANT TREATMENT FOR MELANOMA TO PREVENT RELAPSE FOLLOWING SURGERY!

[amykjones]

We want to share some great news for all our Adjuvant Patients! Health Canada has just approved the use of a combination therapy of Tafinlar® (dabrafenib) plus Mekinist® (trametinib) to prevent recurrence of melanoma following surgery in patients with a stage II or stage III diagnosis, also referred to as ‘adjuvant’ treatment. Click below to read our full press release.

saveyourskin.ca/wp-content/...

[nataliemelanoma Administrator SYSF Ambassador SYSF]

This is great news indeed. But now we have to hope (and wait) to see this approved in each province and territory.